Synlait's back
OPINION: After years of financial turmoil, Canterbury milk processor Synlait is now back in business.
Canterbury dairy company Synlait Milk has begun selling a milk powder ingredient it claims is clinically proven to enhance sleep.
An independent clinical trial of its ingredient iNdream3 is said to have proven its efficacy as a sleep promoting ingredient.
The product is made from melatonin-rich milk, collected in the hours of darkness when cows naturally produce increased concentrations of melatonin in their milk. Melatonin is a sleep-promoting hormone that plays a key role in helping humans to regulate their day/night cycle.
“We’ve been developing this product for several years and this clinical trial is a major milestone in proving the ability of iNdream3 to improve sleep,” says Dr Simon Causer, Synlait’s R&D manager.
The product uses melatonin in its natural form, whereas in almost all other products it is synthetically produced or extracted from source materials with lower levels of melatonin, Synlait says.
The milk powder has been sold in Korea by a Synlait customer since January 2015. Its retail product, Sleepiz, is sold as a powder in a sachet that consumers reconstitute as a drink.
“iNdream3 is an exciting opportunity. It demonstrates our capability as a nutritional business to create and add value for the long term,” says Synlait’s managing director John Penno. “This is a high value product. Synlait and its milk suppliers who provide night milk will benefit, with suppliers receiving a payment above the market milk price.”
Development of the product was funded by Synlait with the help of DairyNZ via the Primary Growth Partnership scheme.
A brilliant result and great news for growers and regional economies. That's how horticulture sector leaders are describing the news that sector exports for the year ended June 30 will reach $8.4 billion - an increase of 19% on last year and is forecast to hit close to $10 billion in 2029.
Funding is proving crucial for predator control despite a broken model reliant on the goodwill of volunteers.
A major milestone on New Zealand's unique journey to eradicate Mycoplasma bovis could come before the end of this year.
We're working through it, and we'll get to it.
The debate around New Zealand's future in the Paris Agreement is heating up.
A technical lab manager for Apata, Phoebe Scherer, has won the Bay of Plenty 2025 Young Grower regional title.